Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0Europace

Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy

  • Federico Migliore
  • Raimondo Pittorru
  • Alberto Cipriani
  • Giulia Winnicki
  • Gaia Zancanaro
  • Jacopo Rosso
  • Sara Pisoni
  • Marco Previtero
  • Veronica Azzolin
  • Manuel De Lazzari
  • Nicolò Martini
  • Alessandro Rizzo
2 more authors
  • Barbara Bauce
  • Domenico Corrado
Read full textDOICite

Abstract

Graphical Abstract: Graphical AbstractFor graphical abstract description, please refer to the textual abstract.

Related

  1. Transient defibrillation threshold elevation associated with air in the generator pocket after extravascular implantable cardioverter-defibrillator implantation.
    Junji Morita, Kenichiro Yamagata, Yuhei Kasai +1
    HeartRhythm case reportsPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  2. Longitudinal Changes in Anxiety and Depression Following First Implantable Cardioverter-Defibrillator Implantation: A Prospective Observational Study
    Vincenzo Sgaramella, Antonio Gianluca Robles, Domenico Rosario Riccardo Chieppa +7
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Successful extravascular implantable cardioverter defibrillator implantation in a patient with ankylosing spondylitis and severe thoracic deformity: a case report.
    Jia He, Qiming Liu, Zean Zhu +2
    European heart journal. Case reportsPeer-reviewedCC BY-NCFull textCardiovascular medicineEurope PMC
  4. Radiofrequency ablation with a conventional solid tip catheter in contact with an implantable cardioverter-defibrillator coil causing inadvertent ventricular fibrillation.
    Michael R Manogue
    HeartRhythm case reportsPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  5. Ventricular fibrillation treated by an implantable cardioverter-defibrillator in antimitochondrial M2 antibody-positive myocarditis.
    Kanto Saida, Atsushi Sudo, Takunori Aoyama +2
    HeartRhythm case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{migliore2026clinical,
  title = {{Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy}},
  author = {Federico Migliore and Raimondo Pittorru and Alberto Cipriani and Giulia Winnicki and Gaia Zancanaro and Jacopo Rosso and Sara Pisoni and Marco Previtero and Veronica Azzolin and Manuel De Lazzari and Nicolò Martini and Alessandro Rizzo and Barbara Bauce and Domenico Corrado},
  journal = {Europace},
  year = {2026},
  month = oct,
  doi = {10.1093/europace/euag284},
  url = {https://doi.org/10.1093/europace/euag284},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy
AU  - Federico Migliore
AU  - Raimondo Pittorru
AU  - Alberto Cipriani
AU  - Giulia Winnicki
AU  - Gaia Zancanaro
AU  - Jacopo Rosso
AU  - Sara Pisoni
AU  - Marco Previtero
AU  - Veronica Azzolin
AU  - Manuel De Lazzari
AU  - Nicolò Martini
AU  - Alessandro Rizzo
AU  - Barbara Bauce
AU  - Domenico Corrado
PY  - 2026
DA  - 2026/10/03
JO  - Europace
DO  - 10.1093/europace/euag284
UR  - https://doi.org/10.1093/europace/euag284
AB  - Graphical Abstract: Graphical AbstractFor graphical abstract description, please refer to the textual abstract.
SN  - 1099-5129
SN  - 1532-2092
ER  -